Please assess the completion status of the following clinical trial:

Trial Title: Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male heterosexual patients aged 22-70 years.~* Confirmed clinical diagnosis of mild, moderate or severe ED for more than 3 months.~* Involved in a continuous heterosexual relationship with their partner for at least 6 months.~Exclusion Criteria:~* Any significant cardiovascular, pulmonary, hepatic, renal, gastrointestinal, haematological, endocrinological, metabolic, neurological or psychiatric disease.~* History of unstable medical or psychiatric condition or using any medication that, in the opinion of the Principal Investigator, is likely to affect the patient's ability to complete the investigation or precludes the patient's participation in the investigation.

- Gender: MALE
- Minimum Age: 22 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- MED3000 (Type: EXPERIMENTAL): MED3000 gel formulation topically applied to the glans penis
- Tadalafil (Type: EXPERIMENTAL): Tadalafil (5 mg) tablets to be taken orally

Based on this trial design, predict the completion outcome and termination type (if applicable).